| Literature DB >> 36015026 |
Caroline Pissetti1, Eduardo de Freitas Costa2, Karoline Silva Zenato1, Marisa Ribeiro de Itapema Cardoso1.
Abstract
Knowledge about antimicrobial resistance in Salmonella is relevant due to its importance in foodborne diseases. We gathered data obtained over 16 years in the southern Brazilian swine production chain to evaluate the temporal evolution of halo for carbapenem, and the MIC for third-generation cephalosporins, fluoroquinolone, and polymyxin in 278 Salmonella Derby and Typhimurium isolates. All antimicrobial resistance assays were performed in accordance with EUCAST. To assess the diameter halo, we used a mixed linear model, and to assess the MIC, an accelerated failure time model for interval-censored data using an exponential distribution was used. The linear predictor of the models comprised fixed effects for matrix, serovar, and the interaction between year, serovar, and matrix. The observed halo diameter has decreased for ertapenem, regardless of serovars and matrices, and for the serovar Typhimurium it has decreased for three carbapenems. The MIC for ciprofloxacin and cefotaxime increased over 16 years for Typhimurium, and for Derby (food) it decreased. We did not find evidence that the MIC for colistin, ceftazidime, ciprofloxacin (Derby), or cefotaxime (food Typhimurium and animal Derby) has changed over time. This work gave an overview of antimicrobial resistance evolution from an epidemiological point of view and observed that using this approach can increase the sensitivity and timeliness of antimicrobial resistance surveillance.Entities:
Keywords: ESBL; antimicrobial resistance; carbapenems; ciprofloxacin; colistin
Year: 2022 PMID: 36015026 PMCID: PMC9414203 DOI: 10.3390/pathogens11080905
Source DB: PubMed Journal: Pathogens ISSN: 2076-0817
Figure 1Observed halo diameter (dots) in millimeters for Salmonella Typhimurium and Derby isolated from animals and food samples between 2000 and 2015 tested against carbapenems (ertapenem, imipenem, and meropenem). Solid lines are the linear predicted trend.
Results for the linear mixed-effects model for assessing the halo diameter in millimeters (mm) against ertapenem, meropenem, and imipenem considering time, the serovars Typhimurium and Derby, and samples obtained from animals and food during the years 2000 and 2015.
| Variable 1 | Estimate | 95% CI 2 | ICC 3 | |
|---|---|---|---|---|
| Ertapenem: | 19.41% | |||
|
| 39.36 | 38.16; 40.53 | - | |
|
| 0.91 | 0.17; 1.7 | 0.02 | |
|
| 0.13 | −1.04; 1.36 | 0.83 | |
|
| −0.36 | −0.57; −0.14 | 0.003 | |
|
| −0.31 | −0.48; −0.14 | 0.001 | |
|
| −0.23 | −0.43; −0.04 | 0.03 | |
|
| −0.16 | −0.32; −0.01 | 0.04 | |
| Imipenem: | 16.8% | |||
|
| 33.21 | 32.00; 34.39 | - | |
|
| −1.3 | −2.03; −0.47 | 0.001 | |
|
| −0.50 | −1.70; 0.66 | 0.41 | |
|
| 0.02 | −0.21; 0.23 | 0.87 | |
|
| −0.24 | −0.42; −0.08 | 0.01 | |
|
| 0.15 | −0.05; 0.34 | 0.13 | |
|
| −0.08 | −0.23; 0.06 | 0.28 | |
| Meropenem: | 15.20% | |||
|
| 37.18 | 36.18; 38.17 | - | |
|
| −1.48 | −2.15; −0.77 | <0.001 | |
|
| −0.31 | −1.35; 0.75 | 0.57 | |
|
| −0.10 | −0.29; 0.08 | 0.29 | |
|
| −0.29 | −0.43; −0.14 | <0.001 | |
|
| 0.05 | −0.11; 0.22 | 0.54 | |
|
| −0.13 | −0.26; −0.002 | 0.06 | |
1 stands for the intercept for serovar Typhimurium and matrix food. is the increment in the for the serovar Derby, and is the increment in the for the matrix food. coefficients are the linear change in the halo diameter per increase of year (slope) for the different combinations of serovar and matrix. 2 CI = Confidence interval. 3 Variance components for Ertapenem model: (); Variance components for Imipenem model: (); Variance components for Meropenem model: ().
Minimum Inhibitory Concentration (MIC) results of Salmonella Derby (n = 135) and Salmonella Typhimurium (n = 278) isolates against different antimicrobials.
| ATM | Source | Serovar | Number of Isolates with MIC (mg/L) Same to: | ECOFF a | R b | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.008 | 0.015 | 0.03 | 0.06 | 0.125 | 0.25 | 0.5 | 1 | 2 | 4 | 8 | 16 | (%) | (%) | |||
|
|
| Derby | 40 | 30 | 12 | 0 | 0 | |||||||||
| Typhimurium | 31 | 29 | 66 | 28 | 11 | 5 | 8 | 2 | 30 | 14.44 | ||||||
|
| Derby | 37 | 16 | 0 | 0 | |||||||||||
| Typhimurium | 12 | 10 | 13 | 12 | 25 | 13 | 8 | 5 c | 64.29 | 52.04 | ||||||
|
|
| Derby | 11 | 61 | 10 | * | 12.20 | |||||||||
| Typhimurium | 15 | 27 | 42 | 85 | 10 | 1 | * | 53.33 | ||||||||
|
| Derby | 5 | 42 | 6 | * | 11.32 | ||||||||||
| Typhimurium | 10 | 46 | 24 | 17 | 1 | * | 18.37 | |||||||||
|
|
| Derby | 4 | 12 | 48 | 17 | 1 | 1.22 | 0 | |||||||
| Typhimurium | 5 | 107 | 64 | 3 | 1 | 2.22 | 0.56 | |||||||||
|
| Derby | 14 | 39 | 0 | 0 | |||||||||||
| Typhimurium | 5 | 41 | 44 | 8 | 8.16 | 0 | ||||||||||
|
|
| Derby | 1 | 7 | 55 | 17 | 1 | 1 | 2.44 | 0 | ||||||
| Typhimurium | 94 | 81 | 5 | 0 | 0 | |||||||||||
|
| Derby | 16 | 35 | 2 | 0 | 0 | ||||||||||
| Typhimurium | 31 | 47 | 19 | 1 | 1.02 | 0 | ||||||||||
a Epidemiological cutoff (ECOFF) values; b Resistant strains (R), as clinical breakpoint values; Gray areas represent MIC values above resistance breakpoint; | represent MIC values above ECOFF; c 4 strains showed MIC > 1; * No data available.
Figure 2Observed median minimum inhibitory concentration (MIC) (dots) in mg/L for Salmonella Typhimurium and Derby isolated from animals and food samples between 2000 and 2015 tested against ciprofloxacin, colistin, ceftazidime, and cefotaxime. Solid lines are the predicted MIC.
Results for the accelerated failure model assessing the minimum inhibitory concentration (MIC) (mg/L) against ciprofloxacin, colistin, ceftazidime, and cefotaxime considering time, the serovars Typhimurium and Derby, and samples obtained from animals and food during the years 2000 and 2015.
| Variable 1 | Estimate | 95% CI 2 | |
|---|---|---|---|
| Ciprofloxacin: | |||
|
| −4 | −4.41; −3.64 | - |
|
| −0.56 | −0.81; −0.31 | <0.001 |
|
| −0.36 | −0.99; 0.26 | 0.27 |
|
| −0.02 | −0.09; 0.05 | 0.62 |
|
| 0.25 | 0.06; 0.43 | 0.01 |
|
| 0 | −0.07; 0.07 | 0.99 |
|
| 0.23 | 0.16; 0.29 | <0.001 |
| Colistin: | |||
|
| 0.82 | 0.55; 1.09 | - |
|
| −0.16 | −0.73; 0.41 | 0.57 |
|
| −0.47 | −0.97; −0.02 | 0.06 |
|
| −0.05 | −0.11; 0.01 | 0.1 |
|
| −0.03 | −0.11; 0.04 | 0.35 |
|
| 0.02 | −0.02; 0.07 | 0.37 |
|
| −0.007 | −0.07; 0.06 | 0.83 |
| Ceftazidime: | |||
|
| −0.6 | −0.72; −0.52 | - |
|
| −0.23 | −0.72; 0.29 | 0.36 |
|
| −0.05 | −0.18; 0.32 | 0.38 |
|
| −0.03 | −0.11; 0.04 | 0.4 |
|
| −0.02 | −0.05; 0.13 | 0.23 |
|
| −0.04 | −0.08; 0.001 | 0.06 |
|
| −0.0002 | −0.03; 0.03 | 0.99 |
| Cefotaxime: | |||
|
| −2.7 | −2.8; −2.6 | - |
|
| 0.53 | 0.2; 0.96 | 0.002 |
|
| 0.2 | 0.04; 0.35 | 0.017 |
|
| −0.02 | −0.08; 0.053 | 0.49 |
|
| 0.03 | 0.011; 0.04 | 0.001 |
|
| −0.06 | −0.1; −0.02 | 0.003 |
|
| 0.017 | −0.001; 0.04 | 0.11 |
1 stands for the intercept for serovar Typhimurium and matrix food. is the increment in the for the serovar Derby, and is the increment in the for the matrix food. coefficients are the log-linear change in the MIC per increase of year (slope) for the different combinations of serovar and matrix. 2 CI = Confidence interval.
Origin of Salmonella Derby and Typhimurium isolates over 16 years, belonging to culture collections of the Preventive Veterinary Medicine Department—Faculty of Veterinary Medicine of Federal University of Rio Grande do Sul (FAVET/UFRGS).
| Collect Year | Number of Isolates— | Reference | |
|---|---|---|---|
| Derby | Typhimurium | ||
| 2000 and 2001 | 25 | 37 | Bessa et al., 2004 [ |
| 2001 | 14 | 30 | Castagna et al., 2004a [ |
| 2001 | 9 | 29 | Castagna et al., 2004b [ |
| 2001 | 0 | 7 | Michael et al., 2002 [ |
| 2003 | 0 | 46 | Silva et al., 2006 [ |
| 2005 | 28 | 25 | Schwarz et al., 2011 [ |
| 2005 and 2006 | 9 | 8 | Murmann et al., 2009 [ |
| 2008 and 2009 | 31 | 30 | Silva et al., 2012 [ |
| 2010 and 2011 | 19 | 53 | Pissetti et al., 2012 [ |
| 2012 | 0 | 5 | Werlang et al., 2019 [ |
| 2014 | 0 | 2 | Werlang et al., 2021 [ |
| 2015 | 0 | 6 | Paim et al., 2019 [ |